Piccina Cintia
SEC insider (Form 3/4/5 filer). CIK 0001907199. U.S. CCO & Country Gen Manager at Autolus Therapeutics plc (AUTL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in LONDON.
Companies Piccina Cintia has filed insider reports for
- Autolus Therapeutics plc (AUTL): Officer, U.S. CCO & Country Gen Manager
- Adaptimmune Therapeutics PLC (ADAP): Officer, Chief Commercial Officer
Piccina Cintia
CIK: 0001907199
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 2, 2026AUTL
Autolus Therapeutics plc
SaleDirect6.7K shares at avg. $2.34$16K - Sep 1, 2026AUTL
Autolus Therapeutics plc
ExerciseDirect20K shares at avg. $2.35$47K - Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.6M shares- - Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.1M shares- - Jan 15, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect13K shares at avg. $0.57$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 |  AUTL Autolus Therapeutics plc | Sale | 6,713 | $2.34 | $15,682 | Direct |
| Sep 1, 2026 | AUTL Autolus Therapeutics plc | Exercise | 20,000 | $2.35 | $47,000 | Direct |
| Feb 20, 2025 |  ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,612,032 | - | - | Direct |
| Feb 20, 2025 | ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,074,696 | - | - | Direct |
| Jan 15, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 12,991 | $0.57 | $7,467 | Direct |
1-5 of 5 transactions